Century Therapeutics (IPSC)Chief Scientific Officer bought ~$49K

~$49K

Approx. value · 58K sh @ $0.8483

1.05M

Holds after · shares reported

Traded

Dec 22, 2025

Filed

Dec 29, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 3, 2025InsiderOfficer sold ~$171 of IPSC shares in the open market
2. Nov 13, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
3. Nov 17, 2025InsiderCEO sold ~$15K of IPSC shares in the open market
4. Nov 19, 2025Insider · First insider buy since Sep 2024CEO purchased ~$17K of IPSC shares in the open market
5. Nov 20, 2025InsiderOfficer sold ~$2.7K of IPSC shares in the open market
6. Dec 8, 2025Insider · 2 peopleInsiders: 2 sales (~$417)
7. Dec 9, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 9, 2025, the Board of Directors (the “Board”) of Century Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from six to eight directors and appointed Dr. Martin Murphy and Dr. Han Lee as directors of the Board, effective as of December 9, 2025 (the “Effective Date”).”
8. Dec 12, 2025Insider · 6 days before an 8-KCEO purchased ~$30K of IPSC shares in the open market
9. Dec 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 18, 2025, Carlo Rizzuto, Ph.D. notified the board of directors (the “Board”) of Century Therapeutics, Inc. (the “Company”) of his intent to resign from the Board, effective December 18, 2025.”
10. Dec 22, 2025 · this disclosureInsider · Their first buy on recordOfficer purchased ~$49K of IPSC shares in the open market

What came next

1. Jan 7, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
2. Feb 3, 2026InsiderOfficer sold ~$589 of IPSC shares in the open market
3. Mar 9, 2026Insider · 2 peopleInsiders: 2 sales (~$2K)
4. Mar 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
5. Mar 12, 2026Insider · 2 peopleInsiders: 2 sales (~$44K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Century Therapeutics

For Century Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IPSC page.

Other recent filings by Chad Cowan, Chief Scientific Officer

• SEC Form 4 at Century Therapeutics (IPSC)Nov 24, 2025

The full history of Chad Cowan, Chief Scientific Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Century Therapeutics

• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 4Aug 5, 2026
• SEC Form 4Jun 15, 2026

Everything OQRO holds on this company is on its IPSC page.